Terms: = Prostate cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824
17 results:
1. Survival Differences in High-Risk prostate cancer by Age.
García Fuentes C; Guijarro A; Hernández V; Gonzalo Á; Jiménez E; De la Peña E; Pérez E; Pérez E; Llorente C
Urol J; 2023 Jul; 20(4):215-221. PubMed ID: 36932725
[TBL] [Abstract] [Full Text] [Related]
2. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before prostate cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries.
MacLennan S; Azevedo N; Duncan E; Dunsmore J; Fullwood L; Lumen N; Plass K; Ribal MJ; Roobol MJ; Nieboer D; Schouten N; Skolarus TA; Smith EJ; N'Dow J; Mottet N; Briganti A;
Eur Urol; 2023 May; 83(5):393-401. PubMed ID: 36639296
[TBL] [Abstract] [Full Text] [Related]
3. Metastatic smarcb1 Deficient Skin Carcinoma With Neuroendocrine Differentiation in the Parotid Glands Clinically Mimicking Primary Salivary Gland Malignancy: Unusual Case With Diagnostic Pitfalls.
Fang F; Zhang QI; Pinto-Cuberos JM; Lai J
Anticancer Res; 2022 Aug; 42(8):3971-3974. PubMed ID: 35896245
[TBL] [Abstract] [Full Text] [Related]
4. Landscape of Cyclin Pathway Genomic Alterations Across 5,356 prostate cancers: Implications for Targeted Therapeutics.
Jardim DL; Millis SZ; Ross JS; Woo MS; Ali SM; Kurzrock R
Oncologist; 2021 Apr; 26(4):e715-e718. PubMed ID: 33522043
[TBL] [Abstract] [Full Text] [Related]
5. Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions.
Jardim DL; Millis SZ; Ross JS; Woo MS; Ali SM; Kurzrock R
Oncologist; 2021 Jan; 26(1):e78-e89. PubMed ID: 32885893
[TBL] [Abstract] [Full Text] [Related]
6. Radiodynamic therapy using 15-MV radiation combined with 5-aminolevulinic acid and carbamide peroxide for prostate cancer in vivo.
Panetta JV; Cvetkovic D; Chen X; Chen L; Ma CC
Phys Med Biol; 2020 Aug; 65(16):165008. PubMed ID: 32464613
[TBL] [Abstract] [Full Text] [Related]
7. Plasmacytoid acinar adenocarcinoma of the prostate: a newly described variant of prostate cancer.
Al-Hussain T; Haffner MC; Altaweel WM; Epstein JI
Hum Pathol; 2019 Dec; 94():86-91. PubMed ID: 31698007
[TBL] [Abstract] [Full Text] [Related]
8. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
Alpsoy A; Dykhuizen EC
J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
[TBL] [Abstract] [Full Text] [Related]
9. Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysis.
Carneiro A; Baccaglini W; Glina FPA; Kayano PP; Nunes VM; Smaletz O; Bernardo WM; Carvalho IT; Lemos GC
Int Braz J Urol; 2017; 43(4):588-599. PubMed ID: 27802009
[TBL] [Abstract] [Full Text] [Related]
10. Linking the SWI/SNF complex to prostate cancer.
Lee RS; Roberts CW
Nat Genet; 2013 Nov; 45(11):1268-9. PubMed ID: 24165726
[TBL] [Abstract] [Full Text] [Related]
11. The evolving epigenome.
Weichenhan D; Plass C
Hum Mol Genet; 2013 Oct; 22(R1):R1-6. PubMed ID: 23900077
[TBL] [Abstract] [Full Text] [Related]
12. ERG expression in epithelioid sarcoma: a diagnostic pitfall.
Miettinen M; Wang Z; Sarlomo-Rikala M; Abdullaev Z; Pack SD; Fetsch JF
Am J Surg Pathol; 2013 Oct; 37(10):1580-5. PubMed ID: 23774169
[TBL] [Abstract] [Full Text] [Related]
13. Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells.
Alimova I; Birks DK; Harris PS; Knipstein JA; Venkataraman S; Marquez VE; Foreman NK; Vibhakar R
Neuro Oncol; 2013 Feb; 15(2):149-60. PubMed ID: 23190500
[TBL] [Abstract] [Full Text] [Related]
14. Prostatic stromal sarcoma with rhabdoid features.
Kim JY; Cho YM; Ro JY
Ann Diagn Pathol; 2010 Dec; 14(6):453-6. PubMed ID: 21074696
[TBL] [Abstract] [Full Text] [Related]
15. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
Medina PP; Sanchez-Cespedes M
Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
[TBL] [Abstract] [Full Text] [Related]
16. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract] [Full Text] [Related]
17. [Cytology in the positive diagnosis and grading of prostatic cancers: which indications do remain at the time of automatic biopsies and endorectal echography?].
Piaton E
Bull Cancer; 1992; 79(1):67-80. PubMed ID: 1520954
[TBL] [Abstract] [Full Text] [Related]
